Levamisole inhibits angiogenesis in vitro and tumor growth in vivo

Angiogenesis

Volumn 8, Issue 1, 2005, Pages 25-34

  Friis, Tina ^a,b   Engel, Anne Marie ^a,b   Klein, Bjarke Mirner ^a   Rygaard, Jørgen ^b   Houen, Gunnar ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Angiogenesis inhibition; Co culture; Endothelial cells; Levamisole; Transplantation; Tumor growth

Indexed keywords

LEVAMISOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; CANCER TRANSPLANTATION; CELL DIFFERENTIATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VOLUME;

ADENOCARCINOMA; ADJUVANTS, IMMUNOLOGIC; ANGIOGENESIS INHIBITORS; ANIMALS; BREAST NEOPLASMS; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LEVAMISOLE; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; UMBILICAL VEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS;

EID: 24044466477     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10456-005-3588-0     Document Type: Article

References (31)

1. J. Folkman 1972 Anti-angiogenesis: New concept for therapy of solid tumors Ann Surg 175 3 409 16
2. FA. Shepherd 2001 Angiogenesis inhibitors in the treatment of lung cancer Lung Cancer 34 Suppl 3 S81 S89
3. T Friis SB Kjaer AM. Engel 2003 A quantitative ELISA-based co-culture angiogenesis and cell proliferation assay APMIS 111 6 658 68
4. CG Moertel TR Fleming JS. Macdonald 1990 Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma N Engl J Med 322 6 352 8
5. CG Moertel TR Fleming JS. Macdonald 1995 Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report Ann Intern Med 122 5 321 6
6. HM Wang GY. Zhang 2005 Indomethacin suppresses growth of colon cancer via inhibition of angiogenesis in vivo World J Gastroenterol 11 3 340 3
7. D Ingber T Fujita S. Kishimoto 1990 Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth Nature 348 6301 555 7
8. S Hansen DA Grabau FB. Sorensen 2000 The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients Clin Cancer Res 6 1 139 46
9. S Hansen FB Sorensen W. Vach 2004 Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients Histopathology 44 5 428 36
10. EL Lund L Bastholm PE. Kristjansen 2000 Therapeutic synergy of TNP-470 and ionizing radiation: Effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts Clin Cancer Res 6 3 971 8
11. EL Lund C Thorsen MW. Pedersen 2000 Relationship between vessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in small cell lung cancer in vivo and in vitro Clin Cancer Res 6 11 4287 91
12. SB Fox RD Leek MP. Weekes 1995 Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis J Pathol 177 3 275 83
13. SB Fox AL. Harris 2004 Histological quantitation of tumour angiogenesis APMIS 112 7-8 413 30
14. Bossche H Van den PA. Janssen 1967 The biochemical mechanism of action of the anthelmintic drug tetramisole Life Sci 6 16 1781 92
15. Bossche H Van den PA. Janssen 1969 The biochemical mechanism of action of the antinematodal drug tetramisole Biochem Pharmacol 18 1 35 42
16. IG Otterness LB Lachman ML. Bliven 1981 Effects of levamisole on the proliferation of thymic lymphocyte subpopulations Immunopharmacology 3 1 61 9
17. JM Redondo JA Lopez-Guerrero M. Fresno 1987 Potentiation of interleukin-2 activity by levamisole and imidazole Immunol Lett 14 2 111 6
18. C Szeto KM Gillespie PW. Mathieson 2000 Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance Immunology 100 2 217 24
19. G Renoux M. Renoux 1977 Thymus-like activities of sulphur derivatives on T-cell differentiation J Exp Med 145 2 466 71
20. R Van Ginckel W Distelmans M. De Brabander 1992 Levamisole plus 5-fluorouracil inhibits the growth of human colorectal xenografts in nude mice Eur J Cancer 28 6-7 1137 9
21. P Klefstrom L. Nuortio 1991 Levamisole in the treatment of advanced breast cancer. A ten-year follow-up of a randomized study Acta Oncol 30 3 347 52
22. HC Stevenson I Green JM. Hamilton 1991 Levamisole: Known effects on the immune system, clinical results, and future applications to the treatment of cancer J Clin Oncol 9 11 2052 66
23. JS Kovach PA Svingen DJ. Schaid 1992 Levamisole potentiation of fluorouracil antiproliferative activity mimicked by orthovanadate, an inhibitor of tyrosine phosphatase J Natl Cancer Inst 84 7 515 9
24. EA Wiebke NA Grieshop PJ. Loehrer 2003 Antitumor effects of 5-fluorouracil on human colon cancer cell lines: Antagonism by levamisole J Surg Res 111 1 63 9
25. CY Liu YY Lai CJ. Lo 2004 Levamisole modulates prostaglandin E2 production and cyclooxygenase II gene expression in human colonic cancer cells J Surg Res 117 2 223 31
26. A Tatsuguchi K Matsui Y. Shinji 2004 Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue Hum Pathol 35 4 488 95
27. A. Lupulescu 1978 Enhancement of carcinogenesis by prostaglandins in male albino Swiss mice J Natl Cancer Inst 61 1 97 106
28. M Kojima T Morisaki A. Uchiyama 2001 Association of enhanced cyclooxygenase-2 expression with possible local immunosuppression in human colorectal carcinomas Ann Surg Oncol 8 5 458 65
29. M Oka A Inaba T. Uchiyama 1994 Prostaglandin E2 levels and lymphocyte subsets in portal venous drainage of colorectal cancers Am J Surg 167 2 264 7
30. R Pai IL Szabo BA. Soreghan 2001 PGE(2) stimulates VEGF expression in endothelial cells via ERK2/JNK1 signaling pathways Biochem Biophys Res Commun 286 5 923 8
31. M Artwohl T Holzenbein L. Wagner 2000 Levamisole induced apoptosis in cultured vascular endothelial cells Br J Pharmacol 131 8 1577 83